Possible role for chlorpheniramine in the treatment of L-DOPA induced dyskinesia in Parkinson's disease (Journal article)

Karamanakos, P. N./ Pappas, P./ Marselos, M.

Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Animals,Antiparkinson Agents/*adverse effects,Chlorpheniramine/*therapeutic use,Dyskinesia, Drug-Induced/*drug therapy/etiology,Levodopa/*adverse effects,Parkinson Disease/*drug therapy,Serotonin Receptor Agonists/*therapeutic use
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/19208
ISSN: 0928-1231
Link: http://www.ncbi.nlm.nih.gov/pubmed/17597418
http://www.springerlink.com/content/6115214433727j22/fulltext.pdf
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Karamanakos-2008-Possible role for ch.pdf107.01 kBAdobe PDFView/Open    Request a copy


 Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/19208
  This item is a favorite for 0 people.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.